iOP107

General

Cell Line

hPSCreg name KCLi002-A
Cite as:
KCLi002-A (RRID:CVCL_UK21)
Alternative name(s)
iOP107
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
KCLi003-A
(iOP101)
Donor's gene variants:
Filaggrin
Donor diseases:
atopic eczema
KCLi001-A
(iOP118)
Donor's gene variants:
Filaggrin
Donor diseases:
atopic eczema
Last update 22nd May 2019
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator King's College London (KCL)
Owner King's College London (KCL)
Derivation country United Kingdom

External Databases

BioSamples SAMEA4932836
Cellosaurus CVCL_UK21
Wikidata Q94337748

General Information

Publications
* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex female
Ethnicity Caucasian

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation.
Synonyms
  • Dermatitis, Atopic
  • Atopic Neurodermatitides
  • Infantile Eczema
  • Atopic Dermatitis
  • Atopic dermatitis and related conditions (disorder)
  • Neurodermatitides, Atopic
  • Other atopic dermatitis and related conditions
  • atopic dermatitis and related conditions
  • Dermatitides, Atopic
  • Disseminated Neurodermatitis
  • Eczema, Infantile
  • Atopic Dermatitides
  • Eczema, Atopic
  • Neurodermatitis, Atopic
  • Disseminated Neurodermatitides
  • Atopic Neurodermatitis
  • Neurodermatitides, Disseminated
  • OTHER ATOPIC DERMATITIS
  • Neurodermatitis, Disseminated
  • Atopic neurodermatitis
  • allergic form of dermatitis
  • eczematous dermatitis
  • Atopic dermatitis
  • eczema
  • Besnier's prurigo
  • atopic eczema
  • allergic
  • allergic dermatitis
show more synonyms
Genetic variants
Filaggrin (target)
Heterozygous

Karyotyping (Donor)

Has the donor karyotype been analysed?
Yes

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
Yes

External Databases (Donor)

BioSamples SAMEA4932837

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: ethikkommission@i-med.ac.at
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink ethikkommission@i-med.ac.at
Alternatives to consent
Alternative consent approval number
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Details on restriction to research project
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Please describe how access is provided:
Contact data, institution, or website:
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Ethics Committee of the Medical University of Innsbruck, Austria
Approval number AN2016-0260
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Ethics Committee of the Medical University of Innsbruck, Austria
Approval number AN2016-0260
Please describe:
Further constraints on use
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Constraints for use or distribution

hIPSC Derivation

General

Source cell type
An epidermal cell which synthesizes keratin and undergoes a characteristic change as it moves upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.; Keratinocytes are reportedly CDw210a-negative, CDw210b-positive, CD281-positive, CD282-positive, CD285-positive, IL22Ra1-positive, Human keratinocytes are reportedly capable of secreting BD-2, BD-3, hCAP-18, CXCL1, CXCL5, CXCL8, elafin, MMP-3, NGAL, PDGF-A, S100A7, S100A8, and S100A9. Transcription factors: STAT3-positive.
Synonyms
  • keratinized cell of epidermis
  • malpighian cell
Source cell origin
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
Synonyms
  • portion of skin
  • region of skin
  • skin
  • skin region
  • skin zone
show more synonyms
Passage number reprogrammed 2

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
Yes
Methods used
RT-PCR
Notes on reprogramming vector detection After ten passages, the elimination of the SeV vectors was confirmed in the KCLi002-A cell line by RT-PCR using specific primers
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Selection criteria for clones Three weeks post-transduction colonies with ES-like morphology appeared and were selected to establish feeder-free iPSC clones
Derived under xeno-free conditions
Yes
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells Irradiated Human Foreskin Fibroblasts (HFF)
Passage method Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
O2 Concentration 5 %
CO2 Concentration 5 %
Medium mTeSR™ 2
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
POU5F1 (OCT-4)
Yes
TRA 1-60
Yes
TRA 1-81
Yes
Alkaline Phosphatase
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vivo teratoma
In vitro spontaneous differentiation
Morphology
Mesoderm
Ont Id: UBERON_0000926
In vivo teratoma
In vitro spontaneous differentiation
Ectoderm
Ont Id: UBERON_0000924
In vivo teratoma
In vitro spontaneous differentiation
In vitro directed differentiation

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XX
Passage number: 14
Karyotyping method: Array CGH

Other Genotyping (Cell Line)